Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found ...
For years, Boston Scientific's factory tests revealed pacemaker batteries that were failing unexpectedly, according to ...
Explore how a 1992 Law & Order episode eerily mirrors Boston Scientific's real-life pacemaker battery issues, raising ...
A new innovation in cardiac surgery. A patient suffering from an arrhythmia—which could not be treated with standard ...
GlobalData on MSN
Medtronic’s OmniaSecure defib lead nets another FDA approval
OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...
The Philadelphia Phillies offered a surprising update on Daniel Robert after a second straight collapse on the mound.
But taken together, the requests formed a pattern — one that, in retrospect, traced a regulatory trail that would later reveal unexpectedly high pacemaker battery failure rates, jeopardizing the lives ...
CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease.
Global medical technology firm with diversified therapeutic portfolio Strong institutional backing reflects broad market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results